Singapore opens CBRNE@Changi near Changi airport to boost pandemic preparedness

Singapore has launched a new Chemical, Biological, Radiological, Nuclear, and Explosives (CBRNE) laboratory near Changi ...

January 16, 2026 | Friday | News
Navigation and evaluation of the 'Long COVID' impact on Asia's public health

The SARS CoV-2 infection can cause a wide range of recurring or persistent health concerns among the populations infecte...

May 8, 2024 | Wednesday | Opinion
Singapore's Duke-NUS scientists discover potential nasal COVID-19 vaccine candidate

A team of scientists, led by Singapore’s Duke-NUS Medical School, has discovered a potential intranasal vaccine ca...

January 10, 2024 | Wednesday | News
Daiichi Sankyo to supply omicron XBB.1.5-adapted COVID-19 vaccine in Japan

Daiichi Sankyo has reached an agreement with Japan’s Ministry of Health, Labour and Welfare (MHLW) to supply the o...

November 22, 2023 | Wednesday | News
New study in Singapore highlights need for refreshed vaccination strategies

Scientists led by a team from Duke-NUS Medical School in Singapore have identified three distinct serotypes of SARS-rela...

August 25, 2023 | Friday | News
Singapore develops antibodies to potentially prevent future coronavirus outbreaks

Exceptionally potent antibodies that can neutralise virtually all known variants of the COVID-19 virus—including O...

July 31, 2023 | Monday | News
CSPC Pharma partners with Pfizer for oral COVID-19 treatment in China

CSPC Pharmaceutical Group has signed a strategic partnership agreement with American pharma firm Pfizer to la...

July 3, 2023 | Monday | News
Korea's SK bioscience receives WHO Emergency Use Listing of COVID-19 vaccine

South Korea-based SK bioscience has received the World Health Organisation (WHO) Emergency Use Listing (EUL) of its COVI...

June 20, 2023 | Tuesday | News
COVID-19 can cause brain cells to ‘fuse’: Australian study

Researchers at The University of Queensland (UQ) in Australia have discovered viruses such as SARS-CoV-2 can cause brain...

June 14, 2023 | Wednesday | News
SK bioscience receives marketing authorisation of COVID-19 vaccine in UK

SK bioscience, based in South Korea, has announced the UK’s Medicines and Healthcare products Regulatory Agency (M...

May 31, 2023 | Wednesday | News
Survey: One-third of COVID-19 vulnerable groups avoid booster shots

The results from a new YouGov survey called, ‘What’s Next for COVID-19 in Singapore?’, commissioned by...

April 25, 2023 | Tuesday | Company results
Taiwan approves Japan-based Chugai Pharma's drug for COVID-19 treatment

Chugai Pharma Taiwan Ltd., a wholly-owned subsidiary of Japan's Chugai Pharmaceutical, has obtained an import drug licen...

April 26, 2023 | Wednesday | News
Australian government injects $50 M more for research into long COVID

The Australian Government will provide a further $50 million from the Medical Research Future Fund (MRFF) for research i...

April 24, 2023 | Monday | News
Taiwan expands eligibility for using Moderna's COVID-19 vaccine as booster for children

The Central Epidemic Command Center (CECC) in Taiwan has reported that the Advisory Committee on Immunisation Practices ...

April 17, 2023 | Monday | News
NZ-based diagnostic startup Pictor raises $5 M for product development

New Zealand (NZ)-based startup Pictor, with operations in US and India, has announced a funding round to help accelerate...

December 6, 2022 | Tuesday | News
CanSino Biologics rolls out inhaled vaccine Convidecia Air in Shanghai

CanSino Biologics has announced that its recombinant COVID-19 vaccine (Adenovirus Type 5 Vector) for inhalation (Convide...

November 1, 2022 | Tuesday | News
Singapore authorises Pfizer's COVID-19 vaccine for kids

The Health Sciences Authority (HSA) has authorised Pfizer’s Comirnaty COVID-19 vaccine on 28 September 2022, for t...

September 30, 2022 | Friday | News
China's BGI donates Huo-Yan Air Laboratory to Thailand

On September 19, 2022, Anutin Charnvirakul, Deputy Prime Minister and Minister of Public Health, Dr Satit Pitutecha, Dep...

September 20, 2022 | Tuesday | News
Australia identifies unique biomarkers of SARS-CoV-2 acute infections, Long COVID

Researchers at the Australian National Phenome Centre (ANPC) at Murdoch University have successfully detected and quanti...

September 21, 2022 | Wednesday | News
Singapore grants interim authorisation for first bivalent COVID-19 booster vaccine

Singapore Health Sciences Authority (HSA) has granted an interim authorisation for the use of Moderna’s Omicr...

September 14, 2022 | Wednesday | News
Australia to focus research on five virus families likely to cause future pandemics

The Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia's national science agency,...

August 30, 2022 | Tuesday | News
Pfizer emerges as leading company in Asia for COVID-19 response

Pfizer has been ranked first in its COVID-19 response, patient centricity, patient safety and bringing innovative, high-...

August 27, 2022 | Saturday | News
Singapore extends use of Moderna's COVID-19 vaccine for kids

  The Health Sciences Authority (HSA) in Singapore has extended the authorisation of Moderna’s Spikevax COVI...

August 24, 2022 | Wednesday | News
Long COVID-19 study in Australia identifies potential diagnostic and therapeutic targets

Australia-based Antisense Therapeutics has announced the outcomes from its collaboration to study the neurological aspec...

August 23, 2022 | Tuesday | News
Mitigate COVID-19 impact on the Construction Industry

The city-state Singapore is currently facing another wave of COVID-19 infections driven by the Omicron variants, BA.5 an...

August 22, 2022 | Monday | News
USFDA grants EUA to Novavax COVID-19 vaccine for adolescents

Novavax has announced that its COVID-19 caccine, Adjuvanted (NVX-CoV2373) has received expanded emergency use autho...

August 22, 2022 | Monday | News
Nuvaxovid gets expanded provisional approval in NZ as COVID-19 booster for adults

US-based Novavax has announced that New Zealand (NZ)'s Medsafe has granted expanded provisional approval for Nuvaxovid (...

August 18, 2022 | Thursday | News
Frontier Biotechnologies proposes treatments for acute and prolonged COVID

China-headquartered global biopharmaceutical company Frontier Biotechnologies announced positive results from the Phase ...

August 15, 2022 | Monday | News
South Korea approves Nuvaxovid COVID-19 vaccine for use in adolescents

US-based Novavax, Inc. has announced that partner, SK bioscience, has received a Post Approval Change Application approv...

August 14, 2022 | Sunday | News
ADB approves $10 M for COVID-19 vaccines in Bhutan

The Asian Development Bank (ADB) has approved a $10 million loan to help the Government of Bhutan purchase safe and effe...

August 2, 2022 | Tuesday | News
Singapore grants interim authorisation for AstraZeneca’s antiviral mAb Evusheld

The Health Sciences Authority (HSA) in Singapore, in consultation with its Medicines Advisory Committee, has, gran...

August 5, 2022 | Friday | News
SK bioscience seeks European approval for COVID-19 vaccine

South Korea-based SK bioscience, a global innovative vaccine and biotech company dedicated to promoting human health fro...

August 3, 2022 | Wednesday | News
Japan approves Novavax's COVID-19 vaccine for adolescents

US-based Novavax has announced that Nuvaxovid (NVX-CoV2373) COVID-19 vaccine received expanded manufacturing and marketi...

July 28, 2022 | Thursday | News
NTU Singapore wins S$2.8 M grant for antiviral drug research

A team of scientists led by Lee Kong Chian School of Medicine (LKCMedicine) at Nanyang Technological University, Singapo...

July 26, 2022 | Tuesday | News
SK bioscience to manufacture Novavax' COVID-19 vaccine against omicron

South Korea's SK bioscience has extended its partnership with Novavax, a US-based biotechnology company specializing in ...

July 22, 2022 | Friday | News
Australia provisionally approves Moderna's COVID-19 vaccine for kids below 6 yrs

US-based Moderna has announced that the Therapeutic Goods Administration (TGA) in Australia has granted provisional regi...

July 19, 2022 | Tuesday | News
Brii Bio advances commercialisation of COVID-19 neutralizing antibody therapy in China

Brii Biosciences has announced that TSB Therapeutics (Beijing),  a joint venture majority-owned by the company, is ...

July 19, 2022 | Tuesday | News
SINOVAC COVID-19 vaccine gets EUA for kids aged 3-5 in Brazil

Sinovac Biotech, a leading provider of biopharmaceutical products in China, has announced that its COVID-19 vaccine (Cor...

July 15, 2022 | Friday | News
Australia uses machine learning to provide early warning for emerging COVID-19 variants

Researchers at the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia’s national scie...

July 11, 2022 | Monday | News
Japan's Shionogi seeks China approval for COVID-19 treatment

Shionogi & Co., has announced that a joint venture between Shionogi and Ping An Life Insurance Company of China, , P...

July 8, 2022 | Friday | News
Brii Biosciences launches long-acting COVID-19 neutralizing antibody therapy in China

Brii Biosciences, a multi-national company developing innovative therapies for diseases with significant unmet medi...

July 11, 2022 | Monday | News
Sinovac starts Omicron-specific inactivated vaccine trial for booster use in China

A kick off ceremony was held at Gleneagles Hospital Hong Kong (Gleneagles or GHK) for initiating a clinical trial to ass...

July 5, 2022 | Tuesday | News
Korea accelerates vaccine sovereignty by developing domestic COVID-19 vaccines

SK bioscience has announced that ‘SKYCovione,’ South Korea’s first COVID-19 vaccine candidate adjuvant...

July 1, 2022 | Friday | News
China's COVID-19 Homologous Booster demonstrates cross-neutralization against Omicron

China's Clover Biopharmaceuticals, a global clinical-stage biotechnology company developing novel vaccines and biol...

June 29, 2022 | Wednesday | News
Australia's EnGeneIC brings 2nd-Gen COVID-19 vaccine against all variants

Australian biopharma company EnGeneIC is developing the world’s first COVID-19 vaccine which can offer immunity ag...

June 29, 2022 | Wednesday | News
Facilitating pandemic preparedness in the Asia Pacific through technology transfer initiatives

Asia Pacific is home to more than half of the world’s population and bears a significant burden of infectious dise...

June 27, 2022 | Monday | Influencers
Ainos COVID-19 antigen self-test receives approval for sale in Taiwan

US-based Ainos, a diversified medtech company focused on the development of novel point-of-care testing, low-dose interf...

June 24, 2022 | Friday | News
2022 Tang Prize from Taiwan honours scientists for developing COVID-19 mRNA vaccines

After the 2014 and 2016 winners for the Tang Prize in Biopharmaceutical Sciences were crowned the Nobel Prize in 2018 an...

June 20, 2022 | Monday | News
G20 meeting proposes mobilisation of financial resources to face future pandemics

During June 6 to 8 June 2022, G20 member states discuss the mobilisation of financial resources to respond to ...

June 9, 2022 | Thursday | News
Moderna to become marketing authorization holder in Japan for Spikevax COVID-19 Vaccine

Moderna and Takeda have announced to transfer the marketing authorization in Japan for Moderna’s COVID-1...

June 2, 2022 | Thursday | News
Seegene unveils '$12 PCR testing' initiative to help end COVID-19 pandemic

Seegene Inc., South Korea's leading molecular diagnostics (MDx) company, has unveiled a global initiative for ...

May 26, 2022 | Thursday | News
Insilico Medicine explores use of 3CL protease inhibitor for COVID-19 treatment

Insilico Medicine, a China & US-based clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery c...

May 25, 2022 | Wednesday | News
US FDA approves Lilly's COVID-19 drug

Eli Lilly and Company and Incyte have announced that the U.S. Food and Drug Administration (FDA) has approved OLUMIANT&n...

May 16, 2022 | Monday | News
ENA Respiratory joins initiative to boost development of antiviral nasal spray

Australia's ENA Respiratory, a clinical-stage pharmaceutical company developing INNA-051, a first-in-class broad-sp...

May 16, 2022 | Monday | News
New study in Thailand highlights effectiveness of SaNOtize nasal spray against COVID-19

Canada-based SaNOtize Research and Development has announced results from a retrospective clinical study assessing the e...

May 11, 2022 | Wednesday | News
US FDA limits use of Janssen COVID-19 vaccine to certain individuals

The US Food and Drug Administration (FDA) has limited the authorized use of the Janssen COVID-19 vaccine to individuals ...

May 6, 2022 | Friday | News
China approves phase 2 trial of recombinant protein COVID-19 vaccine, ReCOV

Jiangsu Recbio Technology Co., Ltd. has recently received the clinical trial approval for its recombinant protein COVID-...

May 5, 2022 | Thursday | News
Taiwan strengthens COVID-19 testing capacity with new screening & reporting systems

The Central Epidemic Command Center (CECC) in Taiwan has launched a contact tracing self-reporting system for confirmed ...

May 3, 2022 | Tuesday | News
SK bioscience reaches final stage of developing Korea´s first COVID-19 vaccine

South Korea-based SK bioscience and GSK have announced submission of a biologics license application for SKYCovione a re...

May 2, 2022 | Monday | News
Healion Bio, FUJIFILM Toyama co-explore promising COVID-19 oral antiviral drug

Healion Bio, a closely held biotechnology company, has announced a collaborative agreement to research a combination ant...

April 29, 2022 | Friday | News
Shionogi’s COVID-19 antiviral drug shows rapid virus clearance

Japan-based Shionogi & Co., Ltd. announced new results from two late-breaking presentations of S-217622 at the 32nd ...

April 28, 2022 | Thursday | News
Hong Kong holds first clinical trial of novel oral treatment for COVID-19

The Chinese University of Hong Kong (CUHK)’s Clinical Trial Centre has announced its collaboration with CUHK Medic...

April 28, 2022 | Thursday | News
China releases first international COVID-19 testing standard

According to the State Administration for Market Regulation in China, the International Organization for Standardization...

April 26, 2022 | Tuesday | News
Japan-Australia-India-U.S. (Quad) donate COVID-19 vaccines to Thailand

Based on the needs of the government of Thailand, approximately 200,000 doses of vaccines manufactured in India were joi...

April 22, 2022 | Friday | News
Australia-based SpeeDx expands COVID-19 diagnostics to include self-collected samples

Australia's SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, has added saliva to the list of ...

April 22, 2022 | Friday | News
Japan approves Novavax's COVID-19 vaccine for primary and booster immunisation

Takeda Pharma has received manufacturing and marketing approval from the Japan Ministry of Health, Labour and Welfare (M...

April 19, 2022 | Tuesday | News
Myopericarditis risk after COVID-19 vaccination is low: Singapore researchers

Globally, more than 10 billion doses of COVID-19 vaccines have been administered as of March 2022. While most side...

April 18, 2022 | Monday | News
UAE approves late stage trial of Jiangsu's COVID-19 vaccine

China's Jiangsu Recbio Technology has received approval from the Ministry of Health and Prevention of the United Arab Em...

April 13, 2022 | Wednesday | News
Live Webinar: Staying Ahead of Viral Variants: Surveillance Solutions for SARS-CoV-2

Click here to register now   Event Details Date: Friday, 29 April 2022 Time: 10:00 AM (GMT+8; Singapore and Tai...

April 11, 2022 | Monday | News
Hong Kong discovers distinct gut microbial signatures for 'long COVID'

Clinical researchers from The Chinese University of Hong Kong's (CUHK) Faculty of Medicine (CU Medicine) have identified...

April 11, 2022 | Monday | News
Thailand gives Emergency Use Authorisation for Novavax' COVID-19 vaccine

US-based Novavax, Inc. and Serum Institute of India have announced that the Thailand Food and Drug Administration (Thai ...

April 8, 2022 | Friday | News
Medriva announces availability of new COVID-19 Rapid Antigen Test kits in Australia

Medriva, a leading global manufacturer of COVID-19 testing and vaccination products, has announced the Australian a...

April 8, 2022 | Friday | News
ResApp announces positive results for new novel smartphone-based COVID-19 screening test

ResApp Health, a leading digital health company developing smartphone applications for the diagnosis and management of r...

March 28, 2022 | Monday | News
Chinese startup iMeddy provides free video medical consultation to COVID-19 patients

Amid the severity of the fifth wave of the COVID-19 pandemic, a startup nurtured by The Hong Kong Polytechnic University...

March 25, 2022 | Friday | News
Singapore recommends second booster dose of mRNA vaccine for 80+

The Expert Committee on COVID-19 Vaccination (EC19V) in Singapore has been closely reviewing the data regarding the need...

March 25, 2022 | Friday | News
Australia to manufacture mRNA vaccines against future pandemics

An in-principle agreement was first announced in December last year for a factory to produce 25 million doses a year fro...

March 24, 2022 | Thursday | News
Novavax and SII gets EUA for COVID-19 vaccines for adolescents in India

Novavax, a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infect...

March 23, 2022 | Wednesday | News
Malaysia approves CanSinoBIO's COVID-19 vaccine as heterologous booster

China-based CanSino Biologics has announced that its Recombinant Novel Coronavirus Vaccine (Convidecia) has been approve...

March 23, 2022 | Wednesday | News
Detecting COVID-19 using only a smartphone

ResApp Health announced positive results for a new novel cough audio-based COVID-19 screening test that only requires a ...

March 22, 2022 | Tuesday | News
Hong Kong study finds that smoking increases risk of COVID-19

Researchers from the School of Public Health, LKS Faculty of Medicine of The University of Hong Kong (HKUMed), in collab...

March 9, 2022 | Wednesday | News
WHO updates treatment guidelines for molnupiravir

The World Health Organisation (WHO) has updated its living guidelines on COVID-19 therapeutics to include a conditional ...

March 4, 2022 | Friday | News
Achieving equitable access and universal coverage goals for COVID-19 vaccines

The pandemic has created an unprecedented pressing need for the development of novel vaccines and their equitable distri...

February 4, 2022 | Friday | Opinion
Australia approves Pfizer booster for 16–17 year olds

The Therapeutic Goods Administration (TGA) in Australia has approved the Pfizer COVID-19 booster dose for young people a...

January 28, 2022 | Friday | News
Australia provisionally approves oral COVID-19 pills by Merck & Pfizer

The Therapeutic Goods Administration (TGA) in Australia has issued provisional approval of the first oral treatments for...

January 21, 2022 | Friday | News
Australia pitches $24 M for telehealth to tackle growing cases of omicron

As Omicron case numbers grow, the Australian Government will make temporary changes to Telehealth to give general p...

January 18, 2022 | Tuesday | News
Australia gives recognition to Sputnik V vaccine for international travel

The Therapeutic Goods Administration (TGA) in Australia has determined that an additional COVID-19 vaccine, the two dose...

January 17, 2022 | Monday | News
Singapore recommends booster dose at no later than 9 months

The Expert Committee on COVID-19 Vaccination (EC19V) in Singapore recommends that all vaccinated persons aged 18 years a...

January 6, 2022 | Thursday | News
T-cell responses by vaccines and boosters effective against Omicron: Australian study

Research from the University of Melbourne in Australia and Hong Kong University of Science and Technology (HKU...

January 3, 2022 | Monday | News
Japan-funded study explores antibodies to neutralise omicron

An international team of scientists have identified antibodies that neutralize omicron and other SARS-CoV-2 variants. Th...

December 28, 2021 | Tuesday | News
Nasal spray to fight COVID-19 heads to clinical trial in Australia

An at-home nasal spray treatment for COVID-19 will be put to the test by Melbourne biomedical researchers, as the Univer...

December 24, 2021 | Friday | News
New Zealand approves use of Ronapreve to prevent & treat COVID-19

The Ministry of Health’s medicine regulatory arm Medsafe in New Zealand has approved a new COVID-19 medicine Ronap...

December 23, 2021 | Thursday | News
Hong Kong develops first anti-COVID-19 stainless steel

A team of researchers at the Department of Mechanical Engineering of the Faculty of Engineering of the University of Hon...

December 23, 2021 | Thursday | News
Australia updates COVID-19 calculator for Pfizer vaccine efficacy

The University of Queensland in Australia has updated a calculator to help people understand their risk factors for COVI...

December 22, 2021 | Wednesday | News
Any New Way to Track Omicron Besides the Sequencing?

  WHO has officially appealed to countries that they must enhance surveillance & sequencing efforts to curb Om...

December 16, 2021 | Thursday | News
Fapon Biotech Introduces POCT Test Solution for SARS-CoV-2 Omicron Variant Identification

Omicron variant has showed surging cases in nearly 77 countries around the world in less than one month and seems to bec...

December 15, 2021 | Wednesday | News
Singapore extends use of Pfizer vaccine for children of age 5 to 11

The Health Sciences Authority (HSA) in Singapore has extended the authorisation of Comirnaty COVID-19 vaccine by Pfizer-...

December 13, 2021 | Monday | News
Hong Kong studies impact of Pfizer vaccine on Omicron variant

A recent study jointly conducted by the LKS Faculty of Medicine, The University of Hong Kong (HKUMed) and the Faculty of...

December 13, 2021 | Monday | News
$540 M to continue and expand Australia’s COVID-19 response

The Australian government has invested a further $540 million in response to the COVID-19 pandemic including significant...

December 8, 2021 | Wednesday | News
Korea offers niclosamide-based drug as possible cure for COVID-19 variants

Experimental results have been published for the first time showing that an antiviral drug containing niclosamide, an an...

December 8, 2021 | Wednesday | News
Singapore secures additional supply of mAb sotrovimab for COVID-19 treatment

GlaxoSmithKline (GSK) Singapore has announced an agreement with the Government of Singapore to supply additional doses o...

December 7, 2021 | Tuesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls